60,000sq. ft. facility will manufacture 1,000+ medium-voltage transformers annually and accelerate U.S. energy infrastructure delivery Giga Energy, a U.S.-based manufacturer and developer of critical power infrastructure, today announced its new medium voltage (MV) Houston Factory, a 60,000-square-foot facility that will serve as the company's primary U.S. manufacturing site for medium-voltage transformers. The facility is expected […]

(NASDAQ:CYTK),(NASDAQ:FTRE),(NYSE:MOH),(NASDAQ:SNPS), PHILADELPHIA, Dec. 16, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Cytokinetics, Inc. (NASDAQ: CYTK) shares prior to December

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf GlobeNewswire December 16, 2025 PHILADELPHIA, Dec. 16, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf

Globally, children comprise one in four trafficking victims. Child trafficking is not confined to distant places like Epstein Island or unfamiliar faces-it's happening everywhere, often hidden in plain sight. Behind every statistic is a child: a future stolen and a voice waiting to be heard. That is why Brave Healer Productions is proud to announce

(NasdaqGM:SLXN), Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies, positive German regulatory feedback, and strong preclinical data demonstrating up to 99.7% cancer cell inhibition Regulatory filings in Germany and the EU are planned for Q1 2026,

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer GlobeNewswire December 16, 2025 Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies, positive German regulatory feedback, and

Premier Plus Lending (PPL) is pleased to announce the addition of Chandler Robbins as its newest Senior Mortgage Advisor. Robbins joins PPL at a point of great momentum and will be integral in supporting the firm's expanding footprint across Southern California. Robbins brings a background shaped by hands-on experience, deep curiosity, and a strong command

International Cloud Computing Awards Program Confirms Its Finalists The 2025/26 Cloud Awards- operated by the international awards body of the same name – has today announced its finalists, featuring a range of global leaders in cloud computing. The program covers a broad range of categories across cloud computing, including SaaS, AI, and cybersecurity. Innovations in

Greener Pastures New Zealand, the country's first integrated residency-by-investment and lifestyle advisory firm, today welcomed the passage of theOverseas Investment (National Interest Test and Other Matters) Amendment Act, approved on Friday. The new legislation permits foreign nationals-including applicants under New Zealand's Active Investor Plus (AIP) visa program-to purchase residential property valued at NZD $5 million

Sunrise Capital Investors, LLC (“Sunrise Capital”) announced today that Courtyard Estates, a 67-site, age-restricted mobile home community outside Columbus, Ohio, is the first acquisition to enter its newly launched Growth & Income Fund V. The community offers stable occupancy, strong collections, and 100% tenant-owned homes, providing an immediate foundation of predictable income for the Fund.